VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE
· Real-Time Price · USD
0.40
-1.04 (-72.22%)
At close: Jul 30, 2025, 3:59 PM
VYNE Therapeutics Fail-to-Deliver
Total FTD Shares
4.85K
Below Average
FTD / Avg. Volume
0.70%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jun 11, 2025,
VYNE Therapeutics Inc. has
4,852
shares failed to deliver, representing 0.70%
of the average daily volume of
694,946.1
shares. Over the past year, the monthly average FTD is
9,869
shares, with the current level 51% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jun 11, 2025 | 0.96 | 4.85K | +4752.00% |
| Apr 25, 2025 | 1.88 | 100 | +9900.00% |
| Mar 27, 2025 | 1.71 | 1 | -99.76% |
| Feb 26, 2025 | 2.65 | 409 | -80.78% |
| Jan 16, 2025 | 2.76 | 2.13K | -96.02% |
| Nov 12, 2024 | 3.02 | 53.44K | +981.76% |
| Oct 30, 2024 | 2.69 | 4.94K | +270.31% |
| Sep 30, 2024 | 1.84 | 1.33K | +6570.00% |
| Aug 27, 2024 | 1.85 | 20 | -99.65% |
| Jul 30, 2024 | 1.90 | 5.71K | +61.56% |
| Jun 28, 2024 | 1.97 | 3.53K | +28.24% |
| May 30, 2024 | 2.53 | 2.75K | +1559.64% |
| Apr 17, 2024 | 2.44 | 166 | -16.58% |
| Mar 27, 2024 | 2.83 | 199 | -81.93% |
| Feb 29, 2024 | 2.33 | 1.1K | +588.13% |
| Jan 30, 2024 | 1.80 | 160 | -97.99% |
| Dec 29, 2023 | 2.50 | 7.96K | +1098.19% |
| Nov 30, 2023 | 3.56 | 664 | -74.28% |
| Oct 31, 2023 | 2.77 | 2.58K | +421.62% |
| Sep 29, 2023 | 4.01 | 495 | -92.23% |
| Aug 14, 2023 | 5.40 | 6.37K | +277.04% |
| Jul 14, 2023 | 4.14 | 1.69K | -25.39% |
| Jun 30, 2023 | 4.17 | 2.27K | +1615.91% |
| May 31, 2023 | 6.53 | 132 | -98.72% |
| Apr 28, 2023 | 5.33 | 10.32K | +377.51% |
| Mar 29, 2023 | 2.63 | 2.16K | +216000.00% |
| Feb 23, 2023 | 3.39 | 1 | -99.99% |
| Jan 27, 2023 | 0.24 | 14.43K | n/a |